Market expert Sandip Sabharwal maintains a constructive long-term outlook but stresses selectivity due to near-term risks like rising input costs and competition. He favors midcaps and selective smallcaps, seeing opportunities in consumer durables, while cautioning on financials and quick commerce. Large pharma deals require careful integration and valuation assessment.
10 largecap stocks with upside potential up to 37%. Do you own any?
Trendlyne’s consensus estimates identify 10 BSE large-cap stocks with potential upside of 25% to 37% over the next 12 months. HDFC Bank and HDFC Life